There is clear evidence for this in ovarian cancer where the expression of HOXA9, HOXA10 or HOXA11 confer a serous, endometrioid-like and mucinous-like phenotype respectively [9]. This evidence concerns the gene HOXA11 and ovarian carcinoma.